Working… Menu

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04414618
Recruitment Status : Completed
First Posted : June 4, 2020
Last Update Posted : March 10, 2021
Information provided by (Responsible Party):
RedHill Biopharma Limited

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 26, 2020
Actual Study Completion Date : December 23, 2020